COPD triple approved, can GSK maximise its revenues?
September 19, 2017EU regulators also backed Trelegy
X
COPD triple approved, can GSK maximise its revenues?
https://pharmaphorum.com/news/gsk-launch-copd-triple-therapy-us/
respiratory
AZ signs pact with mRNA specialists Ethris in respiratory disease
August 21, 2017AstraZeneca has signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.
Galapagos and FibroGen drugs offer hope in IPF
August 15, 2017Drugs improve on existing medicines from Boehringer and Roche.
Verona pushes on with COPD drug after £70m fundraiser
August 8, 2017UK biotech hopes RPL554 could be a disease modifying drug.
After Hikma and Mylan fail, Sandoz files Advair generic in US
June 16, 2017FDA accepts Sandoz filing for Advair Diskus generic.
Chiesi backs up COPD triple therapy with real world study
June 5, 2017Italian firm takes on mighty GSK
FDA rejects Sunovion’s nebulised COPD drug
May 30, 2017European regulators back Chiesi COPD triple therapy
May 22, 2017Chiesi takes on Seretide and other lung drugs with Trimbow.
